Alexander Cumbo - 28 Mar 2025 Form 4 Insider Report for Climb Bio, Inc. (CLYM)

Role
Director
Signature
Emily Pimblett, as Attorney-in-Fact
Issuer symbol
CLYM
Transactions as of
28 Mar 2025
Net transactions value
$0
Form type
4
Filing time
01 Apr 2025, 16:19:03 UTC
Previous filing
18 Feb 2025
Next filing
05 Jun 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLYM Stock Option (Right to Buy) Award $0 +80,000 $0.000000 80,000 28 Mar 2025 Common Stock 80,000 $1.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option vest in equal monthly installments from March 28, 2025 (the "Vesting Commencement Date") until the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service.